Document is current
Any future updates will be listed below
-
Authors
Kawagishi, Naoki
Suda, Goki https://orcid.org/0000-0003-0098-9106
Tahata, Yuki
Hikita, Hayato
Kodama, Takahiro
Mochida, Satoshi
Enomoto, Nobuyuki
Mawatari, Seiichi
Kuroda, Hidekatsu
Miki, Daiki
Kurosaki, Masayuki
Hiasa, Yoichi
Kawada, Norifumi
Yamashita, Taro
Yatsuhashi, Hiroshi
Yoshiji, Hitoshi
Kato, Naoya
Takami, Taro
Miyaaki, Hisamitsu
Matsuura, Kentaro
Asahina, Yasuhiro
Itoh, Yoshito
Tateishi, Ryosuke
Nakamoto, Yasunari
Kakazu, Eiji
Terai, Shuji
Shimizu, Masahito
Ueno, Yoshiyuki
Akuta, Norio
Ohara, Masatsugu
Sakamoto, Naoya
Takehara, Tetsuo
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP24fk0210113, JP25fk0210174)
- License Information
-
More Information
Article History
Received: 21 March 2025
Accepted: 10 June 2025
First Online: 20 June 2025
Declarations
:
: Satoshi Mochida received lecture fees from Gilead Sciences, Inc., AbbVie GK., ASKA Pharmaceutical Co., Ltd., Toray Industries Inc., Otsuka Pharmaceutical Co., Ltd., and Eisai Co., Ltd. Takahiro Kodama received lecture fees from AbbVie GK. and Gilead Sciences, Inc. Masayuki Kurosaki received lecture fees from Gilead, AbbVie, Eisai, Chugai, AstraZeneca, Lilly, and Takeda. Yoichi Hiasa received lecture fees from AbbVie GK. and Gilead Sciences, Inc. Norifumi Kawada received research grants from AstraZeneca plc., Bristol Myers Squibb., GlaxoSmithKline plc., MSD co., ltd., Gilead Sciences, Inc., and Novo Nordisk Pharma Ltd.; scholarship grants from AbbVie GK, Eisai Co., Ltd., and Otsuka Pharmaceutical Co.; and lecture fees from AbbVie GK, Gilead Sciences, Inc., and MSD Co., Ltd. Goki Suda received research grants from Gilead Sciences, Inc. Hitoshi Yoshiji received lecture fees from Gilead Sciences Inc. Naoya Kato received research grants from AbbVie G.K., scholarship grants from Gilead Sciences, Inc., and lecture fees from Gilead Sciences, Inc. and AbbVie G.K. Taro Takami received lecture fees from Gilead Sciences, Inc. Yoshito Itoh received scholarship grants from AbbVie Inc., lecture fees from AbbVie Inc. and Gilead Sciences Inc. Shuji Terai received lecture fees from Otsuka, AbbVie, Asuka, Daiichi Sankyo, Chiomu Takedansen, and Gilead Sciences, Inc. Yoshiyuki Ueno received lecture fees from AbbVie Inc. Norio Akuta received lecture fees from AbbVie Inc. Naoya Sakamoto received lecture fees from Chugai Pharmaceutical Co., Ltd. and research grants from Gilead Sciences, Inc. and AbbVie, Inc. Tetsuo Takehara received research grants and lecture fees from AbbVie GK. and Gilead Sciences, Inc. All other authors declare that they have no conflicts of interest to disclose.
